Carl F. Berglind

no photo

Biography

Carl Berglind is a seasoned corporate attorney and executive with over 20 years of experience handling high-stakes corporate matters and mergers and acquisitions (M&A) transactions for companies in the health care industry. Having served many years as in-house counsel or in executive positions with public and private health care and agtech companies, Carl is skilled in creating and executing on strategic objectives and negotiating with constituents across transactions to meet client goals.

Carl focuses his practice on structuring and managing deals and crafting strategies for complex issues in health care acquisitions and other strategic transactions.

Concentrations

•M&A and strategic transactions in the health care and agtech industries
•Corporate governance
•Private equity
•International transactions

Recognition & Leadership

Awards & Accolades

•Listed, The Best Lawyers in America, Corporate Law, 2023-2026

See more ›

Areas of Practice (5)

  • Health Care & FDA Practice
  • Mergers & Acquisitions
  • Food, Beverage & Agribusiness
  • Corporate
  • Private Equity

Education & Credentials

University Attended:
Boston University, B.A., summa cum laude with Distinction, 1997
Law School Attended:
Cornell Law School, J.D., 2000
Year of First Admission:
2001
Admission:
2001, New York; 2004, Colorado
Memberships:

Professional & Community Involvement

•Cornell University Alumni Association
•Member, Regional Club Advisory Committee, 2022-Present
•President, Cornell Club of Colorado, 2018-2022
•Board Member, Cornell Club of Colorado, 2013-2022
•Board Member, National Multiple Sclerosis Society, CO WY Chapter, 2011-2019
•Board Member, SungateKids, 2006-2012

Languages:
Swedish, Native and French, Conversational and Danish, Conversational
Birth Information:
September 8, 1974
Reported Cases:
Experience: Representative Matters: Senior deal professional for Envision Healthcare (Senior Vice President of Strategic Transactions), including 20 closed M&A transactions with aggregate deal value over $1.7 billion June 2013 to February 2017.; Lead attorney for Envision Healthcare's M&A activities, including 30 closed add-on acquisitions from January 2006 to June 2013, with an aggregate transaction value over $700 million.; Sole in-house securities attorney for Envision Healthcare (Associate General Counsel; Corporate Counsel) following Envision's predecessor entity's 2005 IPO through Envision's 2013 IPO.; Lead attorney for Envision Healthcare's international ventures and operations 2006-2014.; The above representations were handled by Mr. Berglind prior to his joining Greenberg Traurig, LLP.; Previous Experience: Chief Executive Officer, Livestock Labs, 2020-2021; Vice President of Mergers & Acquisitions, CEI Vision Partners (CVP), 2018-2019; Envision Healthcare, 2006-2017; Senior Vice President of Strategic Transactions, 2013-2017; In-House Experience: Envision Healthcare, 2006-2017; Associate General Counsel, 2011-2014; Corporate Counsel, 2006-2010
ISLN:
916928825

Peer Reviews

This lawyer does not have peer reviews.

Client Reviews Write a Review

Location

Contact Carl F. Berglind

Contact Information:

www.gtlaw.com/en/professionals/b/berglind-carl-f

Required Fields

Required Fields

Clear All Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.